Covered recipient · General Payments record
SANDRA WIJEKULARATNE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2024
$543.76
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $543.76 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $292.14 | 2 |
| Novo Nordisk AS | $44.94 | 3 |
| GlaxoSmithKline, LLC. | $36.44 | 2 |
| Amgen Inc. | $34.06 | 2 |
| Janssen Pharmaceuticals, Inc | $29.58 | 1 |
| Astellas Pharma US Inc | $26.21 | 1 |
| ABBVIE INC. | $19.05 | 1 |
| Acerta Pharma LLC | $16.43 | 1 |
| Kowa Pharmaceuticals America, Inc. | $16.06 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $15.05 | 1 |
| Lilly USA, LLC | $13.80 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $543.76 | 16 |
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.05 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106336843 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $15.05 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146998008 | CMS |
| Amgen Inc. | $17.13 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208478 | CMS |
| Amgen Inc. | $16.93 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117717824 | CMS |
| Astellas Pharma US Inc | $26.21 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139431190 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.43 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104547682 | CMS |
| GlaxoSmithKline, LLC. | $17.83 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116475460 | CMS |
| GlaxoSmithKline, LLC. | $18.61 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116588691 | CMS |
| Janssen Pharmaceuticals, Inc | $29.58 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077916939 | CMS |
| Kowa Pharmaceuticals America, Inc. | $16.06 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113471603 | CMS |
| Lilly USA, LLC | $13.80 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135391333 | CMS |
| Medtronic, Inc. | $138.50 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119306136 | CMS |
| Medtronic, Inc. | $153.64 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119306138 | CMS |
| Novo Nordisk Inc | $14.17 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097288406 | CMS |
| Novo Nordisk Inc | $16.06 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097655906 | CMS |
| Novo Nordisk Inc | $14.71 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096725532 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.